| Wang, Tao |
| Recruiting | 4 | 400 | RoW | Vitamin C Injection, Suicheng, H20046552, Normal saline | Kunyue Li, Third Affiliated Hospital of Zhengzhou University | Obstetric Labor Complications, Fever | 10/24 | 10/24 | | |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
NCT06049927: A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months |
|
|
| Completed | 3 | 3300 | RoW | Quadrivalent influenza vaccine(0.25ml), Quadrivalent influenza vaccine(0.5ml), Trivalent influenza vaccine(BV), Trivalent influenza vaccine(BY) | Sinovac Biotech Co., Ltd | Seasonal Influenza | 05/24 | 05/24 | | |
NCT06419621: PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic Triple-negative Breast Cancer |
|
|
| Recruiting | 3 | 360 | RoW | PM8002, Nab-Paclitaxel, Placebo | Biotheus Inc. | Triple Negative Breast Cancer(TNBC) | 07/27 | 07/28 | | |
NCT05726110: Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia |
|
|
| Recruiting | 3 | 50 | RoW | Selinexor, KPT-330, Homoharringtonine, HHT, Daunorubicin, DNR, Cytarabine, Ara-C, Granulocyte Colony-Stimulating Factor, G-CSF, Aclacinomycin, ACM | Shanxi Bethune Hospital, Antengene Corporation | Relapsed or Refractory Acute Myeloid Leukemia | 12/24 | 12/24 | | |
| Recruiting | 3 | 314 | RoW | Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F Conjugates for Injection (FS-1502), Control drug: Trastuzumab emtansine (Kadcyla, T-DM1) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | Breast Cancer | 07/25 | 01/26 | | |
NCT05402722: Study of Eribulin in Combination With Anti-PD-1 Antibody in Patients With Metastatic Triple-Negative Breast Cancer |
|
|
| Recruiting | 2 | 30 | RoW | Eribulin, Halaven, anti-PD-1 antibody | Beijing 302 Hospital | TNBC - Triple-Negative Breast Cancer | 12/22 | 06/23 | | |
TQC3721-II-03, NCT06527144: A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease |
|
|
| Recruiting | 2 | 240 | RoW | 3mg TQC3721 Suspension for Inhalation, 6mg TQC3721 Suspension for Inhalation, Placebo TQC3721 suspension for inhalation | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Pulmonary Disease, Chronic Obstructive | 02/25 | 12/25 | | |
NCT06418594: Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis |
|
|
| Recruiting | 2 | 30 | RoW | Adebrelimab, Apatinib, Apatinib Mesylate Tablets, Etoposide, VP-16 | Beijing 302 Hospital | HER2-negative Breast Cancer Brain Metastases | 11/25 | 12/26 | | |
| Recruiting | 2 | 65 | RoW | Candonilimab, Cisplatin, Gemcitabine | West China Hospital | Cholangiocarcinoma Non-resectable | 07/25 | 07/26 | | |
| Recruiting | N/A | 1000 | RoW | Carotid Endarterectomy (CEA), Carotid Artery Stenting (CAS), Hybrid Surgery | Xuanwu Hospital, Beijing | Non-acute Carotid Artery Occlusion | 12/28 | 12/28 | | |
NCT06135194: Efficacy of T-Dxd in the Treatment of HER2-positive BCBM After Prior Pyrotinib |
|
|
| Recruiting | N/A | 30 | RoW | T-DXd, DS-8201 | Beijing 302 Hospital | Breast Cancer | 12/23 | 06/24 | | |
| Recruiting | N/A | 1300 | RoW | MicRNAs battery kits | Shanghai Mental Health Center | Alzheimer Disease | 01/22 | 09/22 | | |
NCT04137926: A Multicenter Study on the Diagnosis and Intervention of New Biomarkers on the Prodromal Stage of Alzheimer's Disease |
|
|
| Recruiting | N/A | 360 | RoW | MicRNAs battery | Shanghai Mental Health Center | Alzheimer's Disease | 08/22 | 11/22 | | |
NCT03810794: Clinical Evaluation on the Therapeutic Effect of Acupuncture Treatment for Alzheimer's Disease |
|
|
| Recruiting | N/A | 180 | RoW | Acupuncture, Donepezil, Donepezil Hydrochloride Tablets | Shanghai University of Traditional Chinese Medicine, Shanghai Mental Health Center, Huashan Hospital | Alzheimer Disease, Cognitive Impairment | 12/24 | 12/24 | | |
NCT03672448: The China Longitudinal Aging Study of Cognitive Impairment |
|
|
| Recruiting | N/A | 10000 | RoW | Naturalistic observation, Normal Aging | Shanghai Mental Health Center | Mild Cognitive Impairment, Alzheimer Disease, Dementia, Vascular, Dementia With Lewy Bodies, Dementia Frontal, Depression, Anxiety | 11/23 | 11/23 | | |
NCT06155032: Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion |
|
|
| Recruiting | N/A | 272 | RoW | Endovascular therapy, EVT group, Best medical management, Best medical management group | First Affiliated Hospital of Wannan Medical College, The First Affiliated Hospital of Anhui Medical University | Stroke, Ischemic, Cerebrovascular; Disorder, Occlusive | 12/25 | 03/26 | | |
NCT05906719: Machine Vision Based MDS-UPDRS III Machine Rating |
|
|
| Recruiting | N/A | 871 | RoW | video recording | Ruijin Hospital, Second Affiliated Hospital of Soochow University, Beijing Hospital, Beijing Tiantan Hospital, Wuhan Union Hospital, China, Fujian Medical University Union Hospital, Guangdong Provincial People's Hospital, West China Hospital | Parkinsonian Disorders, Machine Learning | 04/24 | 04/24 | | |
NCT06412107: Somatic Acupressure for Symptom Cluster Management in Breast Cancer Survivors |
|
|
| Recruiting | N/A | 108 | RoW | True acupressure, Sham acupressure, Usual care | Charles Darwin University, Second Affiliated Hospital of Zunyi Medical University, Zunyi Medical College | Breast Neoplasm Female, Symptom Cluster | 02/25 | 06/25 | | |
NCT06650553: Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study |
|
|
| Recruiting | N/A | 110 | RoW | Clinically diagnosed AA patients are divided into HLA-matched HSCT group and umbilical cord blood-supported haplo-HSCT group. | Shanxi Bethune Hospital | Aplastic Anemias | 06/26 | 07/26 | | |
NCT05834686: HER2 Expression of CTC to Predict Response in HER2-positive Advanced Breast Cancer Patients Treated With ADC |
|
|
| Recruiting | N/A | 50 | RoW | HER2 expression of circulating tumor cells | Beijing 302 Hospital | Breast Cancer | 12/24 | 04/25 | | |
NCT05834699: HER2 Expression of CTC to Predict Response in HER2-low Advanced Breast Cancer Patients Treated With ADC |
|
|
| Recruiting | N/A | 50 | RoW | HER2 expression of circulating tumor cells | Beijing 302 Hospital | Breast Cancer | 12/24 | 04/25 | | |
NCT05905874: Machine Learning-based Models in Prediction of DVT and PTE in AECOPD Patients |
|
|
| Recruiting | N/A | 1000 | RoW | Machine learning-based prediction model | West China Hospital, University of Chinese Academy of Sciences - Shenzhen Hospital, Affiliated Hospital of North Sichuan Medical College, Nanchong Central Hospital | Machine Learning, Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease With Acute Exacerbation, Unspecified, Pulmonary Thromboembolisms, Deep Vein Thrombosis | 12/24 | 12/24 | | |
NCT05870436: A Study on the Diagnostic Value of the Methacholine Choline Provocation Test in the Asthmatic Population |
|
|
| Recruiting | N/A | 1100 | RoW | Methacholine Choline Provocation Test | jingping Zheng, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Asthma | 01/25 | 06/25 | | |
zypg001, NCT06728891: Analysis of Tumor Deposit at the Fusion Site of the Right Gastric Mesentery and Left Gastric Mesentery in the Patients With Gastric Cancer Who Received Proximal Gastrectomy |
|
|
| Not yet recruiting | N/A | 100 | RoW | In addition to routine diagnosis and treatment, no additional intervention measures were taken. | Jichao Qin | Gastric Carcinoma | 12/27 | 12/27 | | |
zytg001, NCT06728878: Analysis of Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy for Gastric Cancer |
|
|
| Not yet recruiting | N/A | 150 | RoW | | Jichao Qin | Gastric Cancers | 12/27 | 12/27 | | |
| Recruiting | N/A | 75 | RoW | Carotid endarterectomy (CEA), Carotid artery stenting (CAS) | Xuanwu Hospital, Beijing | Radiation-induced Carotid Artery Stenosis | 12/26 | 12/27 | | |
NCT05276713: Outcome of Tucidinostat-Based Therapy in HR+ Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitor |
|
|
| Recruiting | N/A | 50 | RoW | Tucidinostat, Chidamide | Beijing 302 Hospital | Breast Cancer | 06/22 | 08/22 | | |
NCT05380999: The Red Blood Cells Based Blood Test for Lung Cancer EARLY Detection |
|
|
| Not yet recruiting | N/A | 852 | NA | Methylation tests of nucleic acids extracted from mature red blood cells (RBCs) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Peking Union Medical College Hospital, Shanghai Chest Hospital, Guangzhou Panyu Central Hospital, My-BioMed Technology （Guangzhou） Co., Ltd. | Lung Cancer, Red Blood Cells, Methylation | 03/25 | 03/26 | | |
| Liu, Qiang |
NCT03384225: CBA Versus FBA Conditioning Followed by Haploidentical Allogeneic HSCT in Treatment of High Risk and Refractory AML |
|
|
| Recruiting | 3 | 120 | RoW | Cladribine, chlorodeoxyadenosine, Fludarabine, Busulfan, busulphan, Cytarabine, cytosine arabinoside | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Changhai Hospital, Xiangya Hospital of Central South University, Tongji Hospital, Wuhan Union Hospital, China, Chengdu PLA General Hospital, Tang-Du Hospital, Fujian Medical University Union Hospital | High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation | 07/22 | 07/22 | | |
NCT03384212: CBA Versus FBA Conditioning Followed by Allogeneic HSCT in Treatment of High Risk and Refractory AML |
|
|
| Recruiting | 3 | 120 | RoW | Cladribine, chlorodeoxyadenosine, Fludarabine, Busulfan, busulphan, Cytarabine, cytosine arabinoside | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Changhai Hospital, Xiangya Hospital of Central South University, Tongji Hospital, Wuhan Union Hospital, China, Chengdu PLA General Hospital, Tang-Du Hospital, Fujian Medical University Union Hospital | High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation | 07/22 | 07/22 | | |
CLOVER, NCT03926091: Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer |
|
|
| Recruiting | 3 | 2172 | RoW | Docetaxel, docetaxel injection, Cyclophosphamide, Cyclophosphamide injection | Fudan University | Breast Cancer | 11/24 | 11/25 | | |
TORCHLIGHT, NCT04085276: Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment |
|
|
| Active, not recruiting | 3 | 531 | RoW | JS001, Nab-Paclitaxel, Placebo | Shanghai Junshi Bioscience Co., Ltd. | Triple-Negative Breast Cancer | 12/24 | 12/25 | | |
NCT06049940: Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old Population |
|
|
| Completed | 3 | 1260 | RoW | Investigational tetanus vaccine, adsorbed, Control tetanus vaccine, adsorbed | Sinovac Life Sciences Co., Ltd. | Tetanus | 10/23 | 03/24 | | |
NCT05159193: Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer |
|
|
| Recruiting | 3 | 372 | RoW | pegylated liposomal doxorubicin (PLD), duomeisu, Doxorubicin Hydrochloride Liposome Injection, cyclophosphamide (C), huanlinxianan, trastuzumab (H), qutuozhudankang, pertuzumab (P), patuozhudankang, docetaxel (T), duoxitasai, carboplatin (Cb), kabo | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, CSPC Ouyi Pharmaceutical Co., Ltd. | Breast Cancer | 10/24 | 01/28 | | |
HLX11-BC301, NCT05346224 / 2022-002189-34: A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer |
|
|
| Active, not recruiting | 3 | 900 | RoW | HLX11, Recombinant anti-HER2 domain II humanized monoclonal antibody injection, EU-Perjeta® | Shanghai Henlius Biotech, Shanghai Henlius Biotech, Inc. | Breast Cancer, Breast Neoplasms, HER2-positive Breast Cancer | 11/24 | 12/25 | | |
NCT02062489: Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients |
|
|
| Recruiting | 3 | 688 | RoW | Tamoxifen, Nolvadex, Placebo | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Breast Cancer | 05/25 | 05/26 | | |
TQB2450-AL2846-III-01, NCT05922345: Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy. |
|
|
| Recruiting | 3 | 518 | RoW | TQB2450 injection, docetaxel injection matching placebo, AL2846 capsules, TQB2450 placebo, docetaxel injection, AL2846 matching placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Non-small Cell Lung Cancer | 08/25 | 12/25 | | |
TQB3616-III-03, NCT05780567: Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer |
|
|
| Recruiting | 3 | 1946 | RoW | TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen, Placebo capsules, Letrozole, Anastrozole, Tamoxifen | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Breast Cancer | 12/26 | 01/27 | | |
Artemis, NCT04803539: A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After Adjuvant Chemotherapy in TNBC |
|
|
| Recruiting | 2/3 | 260 | RoW | capecitabine, capecitabine + camrelizumab + apatinib | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Jiangsu HengRui Medicine Co., Ltd. | Breast Cancer | 09/28 | 09/33 | | |
| Recruiting | 2 | 99 | RoW | MRG002 | Shanghai Miracogen Inc. | Breast Cancer With Liver Metastases | 12/22 | 10/23 | | |
GBMT-209B-P01, NCT06685796: A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast Cancer |
|
|
| Recruiting | 2 | 120 | RoW | BEBT-209 capsules, KCBT-0191, Carboplatin injection, NSC 241240, Gemcitabine hydrochloride for injection, NSC 613327 | BeBetter Med Inc | Advanced Triple-Negative Breast Cancer | 06/26 | 12/26 | | |
NCT05621655: Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers |
|
|
| Active, not recruiting | 2 | 1512 | RoW | Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine, High dose Recombinant Trivalent Subunit Rotavirus Vaccine, Placebo | MAXVAX Biotechnology Limited Liability Company, Henan Center for Disease Control and Prevention | Rotavirus Infections, Rotavirus Gastroenteritis | 04/23 | 04/24 | | |
NCT05945368: A Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BC |
|
|
| Recruiting | 2 | 78 | RoW | Eribulin mesylate injection、Pertuzumab、Trastuzumab, Eribulin+HP | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | HER2-positive Breast Cancer | 02/24 | 02/25 | | |
BL-M07D1-205, NCT06445400: A Study of BL-M07D1, BL-M07D1+Pertuzumab and BL-M07D1+Pertuzumab+Docetaxel in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer |
|
|
| Recruiting | 2 | 120 | RoW | BL-M07D1, Pertuzumab, Docetaxel | Sichuan Baili Pharmaceutical Co., Ltd., Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. | HER2-positive Breast Cancer | 06/26 | 06/26 | | |
NCT05862610: The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC |
|
|
| Not yet recruiting | 2 | 150 | NA | Trilaciclib plus chemotherapy, Trilaciclib+AC-T, Chemotherapy, AC-T | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Breast Neoplasm | 12/26 | 06/27 | | |
Apollo, NCT04501523: A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After NAC in TNBC |
|
|
| Recruiting | 2 | 460 | RoW | Tislelizumab, capecitabine | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Triple-negative Breast Cancer | 08/27 | 08/32 | | |
| Completed | 1/2 | 14 | RoW | Belimumab | Tianjin Medical University General Hospital, Tang-Du Hospital | NMO Spectrum Disorder | 06/23 | 04/24 | | |
BRIGHT, NCT06548802: Efficacy and Safety of Baricitinib in the Post-intracerebral Hemorrhage Pulmonary Injury |
|
|
| Recruiting | 1/2 | 100 | RoW | Baricitinib | Tianjin Medical University General Hospital, First Affiliated Hospital of Fujian Medical University | Pulmonary Injury After Intracerebral Hemorrhage | 06/26 | 06/26 | | |
NCT05792462: Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders |
|
|
| Recruiting | 1/2 | 12 | RoW | Baricitinib | Tianjin Medical University General Hospital, Tang-Du Hospital, The Second Hospital of Shandong University | NMO Spectrum Disorder | 12/25 | 12/25 | | |
NCT06642558: Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above |
|
|
| Recruiting | 1/2 | 522 | RoW | Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)(low dose), Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)(high dose), Placebo (Saline solution) | MAXVAX Biotechnology Limited Liability Company, Henan Center for Disease Control and Prevention | Respiratory Syncytial Virus (RSV) | 06/25 | 02/27 | | |
NCT03260192: Circulating Tumor DNA to Monitor Response to Neoadjuvant Chemotherapy in Breast Cancer |
|
|
| Recruiting | N/A | 150 | RoW | | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Breast Cancer | 12/25 | 12/25 | | |
NCT06422052: Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspepsia Symptoms |
|
|
| Recruiting | N/A | 2242 | RoW | Epidemiological questionnaire and Functional Dyspepsia Symptom Diary（FDSD） | Shanghai Jiao Tong University School of Medicine | Helicobacter Pylori Infection, Dyspepsia | 05/25 | 05/25 | | |
FLAVOUR II, NCT04397211: Angiography-Derived FFR And IVUS for Clinical Outcomes in Patients With Coronary Artery Disease |
|
|
| Active, not recruiting | N/A | 1872 | RoW | Angiography-derived FFR, IVUS | Second Affiliated Hospital, School of Medicine, Zhejiang University, Seoul National University Hospital, Affiliated Hangzhou First People's Hospital, Wuhan University, Peking University Third Hospital, The Affiliated Hospital of Hangzhou Normal University, RenJi Hospital, Second Hospital of Shanxi Medical University, First Affiliated Hospital of Wenzhou Medical University, Second Affiliated Hospital of Wenzhou Medical University, Changxing People's Hospital, The Affiliated Hospital of Medical College, Ningbo University, Jinhua Central Hospital, Shandong University of Traditional Chinese Medicine, Dongyang People's Hospital, The First Affiliated Hospital of Nanchang University, Jining First People's Hospital, Second Affiliated Hospital of Shantou University Medical College, Ulsan University Hospital, Huizhou Municipal Central Hospital, Zhejiang Greentown Cardiovascular Hospital, The Fourth People's Hospital of Jinan, First Affiliated Hospital of Kunming Medical University | Coronary Artery Disease | 09/24 | 09/28 | | |
NCT06228781: Autologous Hematopoietic Stem Cell Transplantation for Refractory Multiple Sclerosis |
|
|
| Not yet recruiting | N/A | 20 | NA | Autologous haemopoietic stem cell transplantation | Tianjin Medical University General Hospital | Multiple Sclerosis | 01/29 | 01/29 | | |
NCT04076111: Patterns of Breast Cancer Management and Prognosis of Breast Cancer in China |
|
|
| Not yet recruiting | N/A | 20000 | RoW | | Fengxi Su | Breast Cancer | 12/25 | 12/25 | | |
NCT04891731: Efficacy and Safety of Leuprorelin 3M in Premenopausal Women With Hormone Receptor-positive Breast Cancer |
|
|
| Not yet recruiting | N/A | 120 | NA | AI or TAM | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Hormone Receptor-positive Breast Cancer | 05/23 | 09/23 | | |
| Zhou, Wenjia |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
| Zhu, Hecheng |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
